Brandner S, McAleenan A, Kelly C, Spiga F, et al. MGMT promoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Systematic Review. Neuro Oncol 2021;23:1457-1469.
PMID: 34467991